25 XP   0   0   10

Neuroone Medical Technologies Corp
Buy, Hold or Sell?

Let's analyse Neuroone Medical Technologies Corp together

PenkeI guess you are interested in Neuroone Medical Technologies Corp. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Neuroone Medical Technologies Corp. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Neuroone Medical Technologies Corp

I send you an email if I find something interesting about Neuroone Medical Technologies Corp.

Quick analysis of Neuroone Medical Technologies Corp (30 sec.)










What can you expect buying and holding a share of Neuroone Medical Technologies Corp? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
$0.17
Expected worth in 1 year
$0.03
How sure are you?
22.5%

+ What do you gain per year?

Total Gains per Share
$-0.14
Return On Investment
-12.1%

For what price can you sell your share?

Current Price per Share
$1.20
Expected price per share
$0.86 - $1.72
How sure are you?
50%

1. Valuation of Neuroone Medical Technologies Corp (5 min.)




Live pricePrice per Share (EOD)

$1.20

Intrinsic Value Per Share

$-6.55 - $-4.06

Total Value Per Share

$-6.38 - $-3.89

2. Growth of Neuroone Medical Technologies Corp (5 min.)




Is Neuroone Medical Technologies Corp growing?

Current yearPrevious yearGrowGrow %
How rich?$4.4m$10.3m-$5.3m-106.3%

How much money is Neuroone Medical Technologies Corp making?

Current yearPrevious yearGrowGrow %
Making money-$3.3m-$2.2m-$1.1m-33.8%
Net Profit Margin-517.8%-5,120.1%--

How much money comes from the company's main activities?

3. Financial Health of Neuroone Medical Technologies Corp (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#270 / 340

Most Revenue
#279 / 340

Most Profit
#204 / 340

Most Efficient
#291 / 340

What can you expect buying and holding a share of Neuroone Medical Technologies Corp? (5 min.)

Welcome investor! Neuroone Medical Technologies Corp's management wants to use your money to grow the business. In return you get a share of Neuroone Medical Technologies Corp.

What can you expect buying and holding a share of Neuroone Medical Technologies Corp?

First you should know what it really means to hold a share of Neuroone Medical Technologies Corp. And how you can make/lose money.

Speculation

The Price per Share of Neuroone Medical Technologies Corp is $1.2. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Neuroone Medical Technologies Corp.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Neuroone Medical Technologies Corp, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.17. Based on the TTM, the Book Value Change Per Share is $-0.04 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.07 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Neuroone Medical Technologies Corp.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.13-10.7%-0.13-10.8%-0.09-7.2%-0.10-8.7%-0.06-5.3%
Usd Book Value Change Per Share-0.07-5.9%-0.04-3.0%-0.07-6.2%0.021.5%0.000.4%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.07-5.9%-0.04-3.0%-0.07-6.2%0.021.5%0.000.4%
Usd Price Per Share1.58-1.32-1.20-2.16-1.52-
Price to Earnings Ratio-3.06--2.53--4.18--6.45--5.05-
Price-to-Total Gains Ratio-22.37--11.90--20.88--26.82--34.53-
Price to Book Ratio9.27-7.11-3.14--1.59--3.02-
Price-to-Total Gains Ratio-22.37--11.90--20.88--26.82--34.53-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.2
Number of shares833
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.040.02
Usd Total Gains Per Share-0.040.02
Gains per Quarter (833 shares)-30.1515.06
Gains per Year (833 shares)-120.5860.24
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-121-13106050
20-241-2520120110
30-362-3730181170
40-482-4940241230
50-603-6150301290
60-723-7360361350
70-844-8570422410
80-965-9780482470
90-1085-10990542530
100-1206-12200602590

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%0.012.00.00.0%0.020.00.00.0%0.040.00.00.0%0.054.00.00.0%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%6.014.00.030.0%9.027.04.022.5%11.036.07.020.4%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%0.00.040.00.0%0.00.054.00.0%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%6.014.00.030.0%9.027.04.022.5%11.036.07.020.4%

Fundamentals of Neuroone Medical Technologies Corp

About Neuroone Medical Technologies Corp

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

Fundamental data was last updated by Penke on 2024-03-21 01:21:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Neuroone Medical Technologies Corp.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Neuroone Medical Technologies Corp earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Neuroone Medical Technologies Corp to the Medical Devices industry mean.
  • A Net Profit Margin of -342.1% means that $-3.42 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Neuroone Medical Technologies Corp:

  • The MRQ is -342.1%. The company is making a huge loss. -2
  • The TTM is -517.8%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-342.1%TTM-517.8%+175.7%
TTM-517.8%YOY-5,120.1%+4,602.3%
TTM-517.8%5Y-2,979.8%+2,462.0%
5Y-2,979.8%10Y-3,131.2%+151.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-342.1%-10.6%-331.5%
TTM-517.8%-20.2%-497.6%
YOY-5,120.1%-14.0%-5,106.1%
5Y-2,979.8%-19.5%-2,960.3%
10Y-3,131.2%-23.8%-3,107.4%
1.1.2. Return on Assets

Shows how efficient Neuroone Medical Technologies Corp is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Neuroone Medical Technologies Corp to the Medical Devices industry mean.
  • -57.4% Return on Assets means that Neuroone Medical Technologies Corp generated $-0.57 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Neuroone Medical Technologies Corp:

  • The MRQ is -57.4%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -51.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-57.4%TTM-51.3%-6.1%
TTM-51.3%YOY-18.6%-32.8%
TTM-51.3%5Y-65.4%+14.0%
5Y-65.4%10Y-816.2%+750.8%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-57.4%-3.0%-54.4%
TTM-51.3%-4.2%-47.1%
YOY-18.6%-4.0%-14.6%
5Y-65.4%-3.8%-61.6%
10Y-816.2%-4.1%-812.1%
1.1.3. Return on Equity

Shows how efficient Neuroone Medical Technologies Corp is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Neuroone Medical Technologies Corp to the Medical Devices industry mean.
  • -75.7% Return on Equity means Neuroone Medical Technologies Corp generated $-0.76 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Neuroone Medical Technologies Corp:

  • The MRQ is -75.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -69.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-75.7%TTM-69.5%-6.2%
TTM-69.5%YOY-21.2%-48.3%
TTM-69.5%5Y-57.0%-12.5%
5Y-57.0%10Y-28.5%-28.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-75.7%-3.5%-72.2%
TTM-69.5%-4.4%-65.1%
YOY-21.2%-4.7%-16.5%
5Y-57.0%-5.7%-51.3%
10Y-28.5%-6.2%-22.3%

1.2. Operating Efficiency of Neuroone Medical Technologies Corp.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Neuroone Medical Technologies Corp is operating .

  • Measures how much profit Neuroone Medical Technologies Corp makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Neuroone Medical Technologies Corp to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Neuroone Medical Technologies Corp:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-433.5%+433.5%
TTM-433.5%YOY-5,133.8%+4,700.4%
TTM-433.5%5Y-2,964.7%+2,531.2%
5Y-2,964.7%10Y-1,629.2%-1,335.4%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--24.5%+24.5%
TTM-433.5%-14.9%-418.6%
YOY-5,133.8%-11.5%-5,122.3%
5Y-2,964.7%-17.1%-2,947.6%
10Y-1,629.2%-20.6%-1,608.6%
1.2.2. Operating Ratio

Measures how efficient Neuroone Medical Technologies Corp is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 5.20 means that the operating costs are $5.20 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Neuroone Medical Technologies Corp:

  • The MRQ is 5.196. The company is inefficient in keeping operating costs low. -1
  • The TTM is 6.383. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ5.196TTM6.383-1.188
TTM6.383YOY52.432-46.049
TTM6.3835Y30.815-24.431
5Y30.81510Y26.937+3.877
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ5.1961.454+3.742
TTM6.3831.452+4.931
YOY52.4321.434+50.998
5Y30.8151.432+29.383
10Y26.9371.366+25.571

1.3. Liquidity of Neuroone Medical Technologies Corp.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Neuroone Medical Technologies Corp is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 3.68 means the company has $3.68 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Neuroone Medical Technologies Corp:

  • The MRQ is 3.682. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.663. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.682TTM3.663+0.019
TTM3.663YOY10.164-6.501
TTM3.6635Y5.525-1.862
5Y5.52510Y2.931+2.594
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ3.6822.789+0.893
TTM3.6632.793+0.870
YOY10.1643.586+6.578
5Y5.5253.492+2.033
10Y2.9313.450-0.519
1.3.2. Quick Ratio

Measures if Neuroone Medical Technologies Corp is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Neuroone Medical Technologies Corp to the Medical Devices industry mean.
  • A Quick Ratio of 0.39 means the company can pay off $0.39 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Neuroone Medical Technologies Corp:

  • The MRQ is 0.393. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 2.218. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ0.393TTM2.218-1.825
TTM2.218YOY10.346-8.128
TTM2.2185Y5.210-2.992
5Y5.21010Y2.734+2.476
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3931.587-1.194
TTM2.2181.633+0.585
YOY10.3462.185+8.161
5Y5.2102.300+2.910
10Y2.7342.255+0.479

1.4. Solvency of Neuroone Medical Technologies Corp.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Neuroone Medical Technologies Corp assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Neuroone Medical Technologies Corp to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.24 means that Neuroone Medical Technologies Corp assets are financed with 24.1% credit (debt) and the remaining percentage (100% - 24.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Neuroone Medical Technologies Corp:

  • The MRQ is 0.241. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.255. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.241TTM0.255-0.014
TTM0.255YOY0.139+0.116
TTM0.2555Y0.904-0.649
5Y0.90410Y30.827-29.923
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2410.400-0.159
TTM0.2550.386-0.131
YOY0.1390.330-0.191
5Y0.9040.440+0.464
10Y30.8270.460+30.367
1.4.2. Debt to Equity Ratio

Measures if Neuroone Medical Technologies Corp is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Neuroone Medical Technologies Corp to the Medical Devices industry mean.
  • A Debt to Equity ratio of 31.8% means that company has $0.32 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Neuroone Medical Technologies Corp:

  • The MRQ is 0.318. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.346. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.318TTM0.346-0.028
TTM0.346YOY0.170+0.176
TTM0.3465Y0.664-0.318
5Y0.66410Y0.332+0.332
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3180.566-0.248
TTM0.3460.569-0.223
YOY0.1700.479-0.309
5Y0.6640.626+0.038
10Y0.3320.692-0.360

2. Market Valuation of Neuroone Medical Technologies Corp

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Neuroone Medical Technologies Corp generates.

  • Above 15 is considered overpriced but always compare Neuroone Medical Technologies Corp to the Medical Devices industry mean.
  • A PE ratio of -3.06 means the investor is paying $-3.06 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Neuroone Medical Technologies Corp:

  • The EOD is -2.326. Based on the earnings, the company is expensive. -2
  • The MRQ is -3.062. Based on the earnings, the company is expensive. -2
  • The TTM is -2.527. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.326MRQ-3.062+0.736
MRQ-3.062TTM-2.527-0.535
TTM-2.527YOY-4.180+1.653
TTM-2.5275Y-6.453+3.926
5Y-6.45310Y-5.047-1.406
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-2.326-1.038-1.288
MRQ-3.062-1.216-1.846
TTM-2.527-1.757-0.770
YOY-4.180-2.582-1.598
5Y-6.453-1.553-4.900
10Y-5.047-1.463-3.584
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Neuroone Medical Technologies Corp:

  • The EOD is -2.022. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.663. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.485. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.022MRQ-2.663+0.640
MRQ-2.663TTM-2.485-0.178
TTM-2.485YOY1.291-3.776
TTM-2.4855Y-4.061+1.576
5Y-4.06110Y-6.013+1.952
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-2.022-1.207-0.815
MRQ-2.663-1.746-0.917
TTM-2.485-2.961+0.476
YOY1.291-6.143+7.434
5Y-4.061-4.928+0.867
10Y-6.013-5.626-0.387
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Neuroone Medical Technologies Corp is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 9.27 means the investor is paying $9.27 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Neuroone Medical Technologies Corp:

  • The EOD is 7.043. Based on the equity, the company is overpriced. -1
  • The MRQ is 9.273. Based on the equity, the company is overpriced. -1
  • The TTM is 7.112. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD7.043MRQ9.273-2.230
MRQ9.273TTM7.112+2.161
TTM7.112YOY3.137+3.975
TTM7.1125Y-1.592+8.704
5Y-1.59210Y-3.020+1.428
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD7.0432.038+5.005
MRQ9.2732.321+6.952
TTM7.1122.444+4.668
YOY3.1373.028+0.109
5Y-1.5923.918-5.510
10Y-3.0204.245-7.265
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Neuroone Medical Technologies Corp.

3.1. Institutions holding Neuroone Medical Technologies Corp

Institutions are holding 25.942% of the shares of Neuroone Medical Technologies Corp.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31Nantahala Capital Management, LLC9.36410.11482428188117818894.255
2023-12-31Vanguard Group Inc3.53870917630478149108.7986
2023-12-31Geode Capital Management, LLC0.760201971211885910.5794
2023-12-31Mayo Clinic0.70091.773718175400
2023-12-31Perkins Capital Management Inc0.57850.202415000000
2023-12-31State Street Corporation0.19905159900
2023-12-31Mccormack Advisors International0.19280.0015000000
2023-12-31Northern Trust Corp0.11680302811034851.9139
2023-12-31Wealth Alliance Advisory Group, LLC0.07520.008119500195000
2023-12-31Virtu Financial LLC0.06990.002318117181170
2023-12-31Princeton Global Asset Management LLC0.06490.00671683300
2023-12-31Tower Research Capital LLC0.01980.0001513751370
2023-12-31Centerpoint Advisors, LLC0.01930.0031500050000
2023-12-31SIMPLEX TRADING, LLC0.01130292029200
2023-12-31UBS Group AG0.00730188517771645.3704
2023-12-31Advisor Group Holdings, Inc.0.00130350-350-50
2023-12-31Wells Fargo & Co0.0007017595.4217
2023-12-31JPMorgan Chase & Co0.00020391350
2023-12-31Bank of America Corp0.0001030-70-70
2023-12-31Goss Wealth Management LLC000-2380-100
Total 15.7212.11224076559+1735217+42.6%

3.2. Funds holding Neuroone Medical Technologies Corp

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Vanguard Total Stock Mkt Idx Inv2.74750.000171245100
2024-01-31Vanguard Institutional Extnd Mkt Idx Tr0.79280.00032055794000.195
2023-12-31Fidelity Extended Market Index0.45270.0005117378-295-0.2507
2023-12-31Fidelity Total Market Index0.10160.00012635500
2023-12-31Northern Trust Extended Eq Market Idx0.08010.000620764916479
2023-12-31NT Ext Equity Mkt Idx Fd - L0.08010.000620764916479
2023-12-31Fidelity Series Total Market Index0.07250.00011878800
2023-12-31Spartan Total Market Index Pool E0.06070.00011573600
2023-12-31Fidelity Nasdaq Composite Index0.05990.00021554000
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.03210.0002833300
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.02580.00026693130.1946
2024-01-31State St US Extended Mkt Indx NL Cl C0.01430.0002370000
2023-12-31SSgA U.S. Extended Market Index Class I0.01430.0002370000
2023-12-31Spartan Extended Market Index Pool E0.01210.0002313529510.3873
2023-12-31Northern Trust Wilshire 50000.00460.0001118411840
2023-12-31NT US Market Cap Idx Fd - L0.00460.0001118411840
2023-12-31SSgA U.S. Total Market Index Strategy0.004101067-25-2.2894
2023-12-31NT Ext Eq Mkt Indx Fd DC Lending Tier 50.0010.000226910.3731
Total 4.56080.0041182620+21085+1.8%

3.3. Insider Transactions

Insiders are holding 12.21% of the shares of Neuroone Medical Technologies Corp.

DateOwnerTypeAmountPricePost Transaction AmountLink
2023-12-26Mark ChristiansonSELL68481.35
2023-12-21Christopher VolkerBUY750001.4
2023-12-21Mark ChristiansonSELL99071.4
2023-09-13Ronald W McclurgBUY509000.98
2023-03-23Mark ChristiansonSELL127111.5
2023-03-21Mark ChristiansonSELL21221.6

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Neuroone Medical Technologies Corp compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.071-0.036-49%-0.075+6%0.018-491%0.004-1747%
Book Value Per Share--0.1700.194-12%0.400-57%0.178-5%0.060+182%
Current Ratio--3.6823.663+1%10.164-64%5.525-33%2.931+26%
Debt To Asset Ratio--0.2410.255-5%0.139+74%0.904-73%30.827-99%
Debt To Equity Ratio--0.3180.346-8%0.170+87%0.664-52%0.332-4%
Dividend Per Share----0%-0%-0%-0%
Eps---0.129-0.130+1%-0.086-33%-0.105-19%-0.064-51%
Free Cash Flow Per Share---0.148-0.131-12%-0.083-44%-0.081-46%-0.045-69%
Free Cash Flow To Equity Per Share---0.102-0.048-53%-0.083-19%0.004-2382%0.003-3283%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.021-2%
Intrinsic Value_10Y_max---4.062--------
Intrinsic Value_10Y_min---6.552--------
Intrinsic Value_1Y_max---0.214--------
Intrinsic Value_1Y_min---0.452--------
Intrinsic Value_3Y_max---0.791--------
Intrinsic Value_3Y_min---1.544--------
Intrinsic Value_5Y_max---1.545--------
Intrinsic Value_5Y_min---2.830--------
Market Cap31117080.000-32%40970822.00034231381.090+20%31187741.703+31%55902223.184-27%39438500.292+4%
Net Profit Margin---3.421-5.178+51%-51.201+1396%-29.798+771%-31.312+815%
Operating Margin----4.3350%-51.3380%-29.6470%-16.2920%
Operating Ratio--5.1966.383-19%52.432-90%30.815-83%26.937-81%
Pb Ratio7.043-32%9.2737.112+30%3.137+196%-1.592+117%-3.020+133%
Pe Ratio-2.326+24%-3.062-2.527-17%-4.180+37%-6.453+111%-5.047+65%
Price Per Share1.200-32%1.5801.320+20%1.203+31%2.156-27%1.521+4%
Price To Free Cash Flow Ratio-2.022+24%-2.663-2.485-7%1.291-306%-4.061+52%-6.013+126%
Price To Total Gains Ratio-16.992+24%-22.373-11.896-47%-20.885-7%-26.818+20%-34.532+54%
Quick Ratio--0.3932.218-82%10.346-96%5.210-92%2.734-86%
Return On Assets---0.574-0.513-11%-0.186-68%-0.654+14%-8.162+1321%
Return On Equity---0.757-0.695-8%-0.212-72%-0.570-25%-0.285-62%
Total Gains Per Share---0.071-0.036-49%-0.075+6%0.018-491%0.004-1747%
Usd Book Value--4418156.0005030420.500-12%10379214.750-57%4626942.200-5%1567301.900+182%
Usd Book Value Change Per Share---0.071-0.036-49%-0.075+6%0.018-491%0.004-1747%
Usd Book Value Per Share--0.1700.194-12%0.400-57%0.178-5%0.060+182%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.129-0.130+1%-0.086-33%-0.105-19%-0.064-51%
Usd Free Cash Flow---3846522.000-3403437.000-12%-2139474.500-44%-2094226.600-46%-1177017.650-69%
Usd Free Cash Flow Per Share---0.148-0.131-12%-0.083-44%-0.081-46%-0.045-69%
Usd Free Cash Flow To Equity Per Share---0.102-0.048-53%-0.083-19%0.004-2382%0.003-3283%
Usd Market Cap31117080.000-32%40970822.00034231381.090+20%31187741.703+31%55902223.184-27%39438500.292+4%
Usd Price Per Share1.200-32%1.5801.320+20%1.203+31%2.156-27%1.521+4%
Usd Profit---3344900.000-3367905.500+1%-2231226.750-33%-2711033.450-19%-1649673.425-51%
Usd Revenue--977649.000703877.750+39%63000.000+1452%260298.550+276%130194.875+651%
Usd Total Gains Per Share---0.071-0.036-49%-0.075+6%0.018-491%0.004-1747%
 EOD+3 -5MRQTTM+14 -18YOY+11 -215Y+8 -2410Y+14 -19

4.2. Fundamental Score

Let's check the fundamental score of Neuroone Medical Technologies Corp based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.326
Price to Book Ratio (EOD)Between0-17.043
Net Profit Margin (MRQ)Greater than0-3.421
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.393
Current Ratio (MRQ)Greater than13.682
Debt to Asset Ratio (MRQ)Less than10.241
Debt to Equity Ratio (MRQ)Less than10.318
Return on Equity (MRQ)Greater than0.15-0.757
Return on Assets (MRQ)Greater than0.05-0.574
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Neuroone Medical Technologies Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.303
Ma 20Greater thanMa 501.175
Ma 50Greater thanMa 1001.215
Ma 100Greater thanMa 2001.320
OpenGreater thanClose1.190
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets5,822
Total Liabilities1,404
Total Stockholder Equity4,418
 As reported
Total Liabilities 1,404
Total Stockholder Equity+ 4,418
Total Assets = 5,822

Assets

Total Assets5,822
Total Current Assets5,093
Long-term Assets729
Total Current Assets
Cash And Cash Equivalents 2,681
Net Receivables 543
Inventory 1,609
Other Current Assets 21
Total Current Assets  (as reported)5,093
Total Current Assets  (calculated)4,854
+/- 239
Long-term Assets
Property Plant Equipment 645
Long-term Assets  (as reported)729
Long-term Assets  (calculated)645
+/- 84

Liabilities & Shareholders' Equity

Total Current Liabilities1,383
Long-term Liabilities21
Total Stockholder Equity4,418
Total Current Liabilities
Accounts payable 760
Total Current Liabilities  (as reported)1,383
Total Current Liabilities  (calculated)760
+/- 623
Long-term Liabilities
Long-term Liabilities  (as reported)21
Long-term Liabilities  (calculated)0
+/- 21
Total Stockholder Equity
Total Stockholder Equity (as reported)4,418
Total Stockholder Equity (calculated)0
+/- 4,418
Other
Capital Stock25
Common Stock Shares Outstanding 24,831
Net Invested Capital 4,418
Net Working Capital 3,710
Property Plant and Equipment Gross 1,033



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-30
> Total Assets 
0
0
9
0
5
5
14
8
6
1
1
1
1
1
1
1
1
1
0
0
0
0
2
2
4
4
760
760
0
268
250
250
230
220
578
2,575
1,536
533
2,659
1,389
4,462
4,760
7,913
11,917
9,809
7,938
17,183
14,089
11,571
12,823
9,660
7,205
5,758
8,097
5,822
5,8228,0975,7587,2059,66012,82311,57114,08917,1837,9389,80911,9177,9134,7604,4621,3892,6595331,5362,5755782202302502502680760760442200001111111116814550900
   > Total Current Assets 
0
0
9
0
5
5
14
8
6
1
1
1
1
1
1
1
1
1
0
0
0
0
2
2
4
4
580
580
0
77
34
34
23
20
383
2,385
1,299
302
2,092
829
3,904
4,155
7,340
11,355
9,271
7,292
16,576
13,443
10,929
12,176
8,967
6,357
4,879
7,313
5,093
5,0937,3134,8796,3578,96712,17610,92913,44316,5767,2929,27111,3557,3404,1553,9048292,0923021,2992,38538320233434770580580442200001111111116814550900
       Cash And Cash Equivalents 
0
0
9
0
5
5
14
8
6
1
1
1
1
1
1
1
1
1
0
0
0
0
2
-2
0
0
520
520
0
70
26
26
23
10
351
2,305
1,247
261
2,044
747
3,824
4,036
7,129
11,274
8,991
6,901
16,184
12,869
10,178
8,160
4,667
3,602
3,083
5,322
2,681
2,6815,3223,0833,6024,6678,16010,17812,86916,1846,9018,99111,2747,1294,0363,8247472,0442611,2472,3053511023262670052052000-2200001111111116814550900
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,981
2,975
995
0
0
0
0009952,9752,9810000000000000000000000000000000000000000000000000
       Net Receivables 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
71
0
40
48
25
37
297
33
95
214
0
0
543
54300214953329737254840071000000000000000000000000000000000000000000
       Other Current Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
4
0
60
0
7
0
7
1
0
10
80
52
41
48
81
80
1
126
81
188
244
137
315
0
297
325
371
279
264
21
2126427937132529703151372441888112618081484152801001707060044000000000000000000000000
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
180
0
191
0
216
206
0
195
189
237
231
567
561
558
605
573
562
537
646
608
646
642
647
693
849
879
784
729
729784879849693647642646608646537562573605558561567231237189195020621601910180000000000000000000000000000
       Property Plant Equipment 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
53
52
393
393
396
448
422
416
398
512
479
523
524
535
587
748
784
695
645
6456957847485875355245234795123984164224483963933935253000000000000000000000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
180
180
0
191
216
216
206
200
195
189
184
179
173
168
162
157
151
145
140
134
129
123
117
112
106
101
95
90
0
09095101106112117123129134140145151157162168173179184189195200206216216191018018000000000000000000000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
269
0
0
7,792
0
0
0
0
0
0
0
0
0
0000000007,79200269000000000000000040000000000000000000000000
> Total Liabilities 
0
0
13
0
17
17
17
17
17
17
18
18
27
29
31
31
20
26
36
36
57
64
83
83
104
110
1,020
105
128
3,797
5,287
5,287
7,518
4,610
5,536
2,130
1,809
1,770
7,271
6,574
8,389
2,694
6,505
1,057
954
1,385
1,236
966
952
3,218
1,488
1,672
1,837
1,848
1,404
1,4041,8481,8371,6721,4883,2189529661,2361,3859541,0576,5052,6948,3896,5747,2711,7701,8092,1305,5364,6107,5185,2875,2873,7971281051,020110104838364573636262031312927181817171717171701300
   > Total Current Liabilities 
0
0
3
0
5
5
5
5
5
5
18
18
27
29
31
31
20
26
36
36
57
64
83
83
104
110
680
105
128
3,022
3,905
3,905
3,302
3,800
4,712
2,130
1,809
1,770
6,973
6,290
8,037
2,356
6,183
750
747
1,182
1,062
810
815
3,099
1,335
1,550
1,748
1,793
1,383
1,3831,7931,7481,5501,3353,0998158101,0621,1827477506,1832,3568,0376,2906,9731,7701,8092,1304,7123,8003,3023,9053,9053,02212810568011010483836457363626203131292718185555550300
       Short-term Debt 
0
0
0
0
4
4
0
4
4
4
0
17
25
27
0
28
0
17
0
2
5
9
14
14
0
0
280
280
0
1,664
2,421
2,421
1,413
1,680
2,186
229
0
0
5,232
4,976
6,784
1,065
59
61
62
113
115
105
94
83
119
122
126
129
0
012912612211983941051151136261591,0656,7844,9765,232002292,1861,6801,4132,4212,4211,6640280280001414952017028027251704440440000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
229
0
0
5,192
4,921
6,728
1,007
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000001,0076,7284,9215,1920022900000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
1
0
9
0
10
9
8
17
11
21
21
0
28
42
0
0
0
82
0
470
688
868
1,152
1,144
1,077
911
763
520
346
296
529
704
446
325
928
862
953
959
685
760
7606859599538629283254467045292963465207639111,0771,1441,152868688470082000422802121111789100901100000000000000
       Other Current Liabilities 
0
0
3
0
1
1
5
1
1
1
18
1
2
2
30
3
20
17
0
3
43
47
0
6
83
88
0
77
87
1,359
540
1,484
1,807
0
2,016
2,421
941
618
597
237
341
455
5,553
313
374
531
483
257
393
1,265
354
475
664
978
0
09786644753541,2653932574835313743135,5534553412375976189412,4212,01601,8071,4845401,359877708883604743301720330221181115110300
   > Long-term Liabilities 
0
0
11
0
13
13
13
13
13
13
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
340
0
774
0
1,381
4,216
0
824
810
0
0
298
284
353
338
322
307
207
203
173
156
138
120
154
122
89
55
21
2155891221541201381561732032073073223383532842980081082404,2161,381077403400000000000000000013131313131301100
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
774
1,381
0
0
0
824
0
0
0
0
0
83
0
83
0
0
0
0
0
0
0
0
0
0
0
0
00000000000083083000008240001,38177400000000000000000000000000000
> Total Stockholder Equity
0
0
-4
0
-12
-12
-3
-9
-11
-16
-17
-17
-26
-28
-30
-30
-19
-26
0
-35
-57
-64
-81
-81
-100
-105
0
-105
-128
-3,529
-5,037
-5,037
-7,289
0
-4,958
445
-273
-1,238
-4,612
-5,185
-3,927
2,066
1,408
10,860
8,855
6,554
15,948
13,122
10,618
9,604
8,172
5,533
3,921
6,249
4,418
4,4186,2493,9215,5338,1729,60410,61813,12215,9486,5548,85510,8601,4082,066-3,927-5,185-4,612-1,238-273445-4,9580-7,289-5,037-5,037-3,529-128-1050-105-100-81-81-64-57-350-26-19-30-30-28-26-17-17-16-11-9-3-12-120-400
   Common Stock
0
0
5
0
5
5
5
5
5
5
5
5
5
5
5
5
5
5
0
5
5
5
5
5
5
5
0
5
5
8
8
8
8
0
10
13
13
13
14
14
18
22
23
36
36
12
40
40
16
16
16
17
18
24
0
024181716161640401236362322181414131313100888855055555550555555555555550500
   Retained Earnings Total Equity0000000000-38,184-35,232-32,839000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 000000000000-450-23-16-11-6-100000000000000000000000000-49-44-420-21-170000
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,224
46,057
47,003
0
0
0
0
0
0
0
0
0
0
000000000047,00346,05734,224000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
-17
4
28
28
28
28
28
28
42
45
46
46
77
77
0
77
89
92
93
93
109
109
0
46
46
163
0
280
646
0
6,842
14,454
15,599
15,988
17,250
18,022
26,368
32,923
34,224
46,057
47,003
47,369
59,542
59,775
60,055
60,415
60,715
61,598
63,455
68,912
0
068,91263,45561,59860,71560,41560,05559,77559,54247,36947,00346,05734,22432,92326,36818,02217,25015,98815,59914,4546,8420646280016346460109109939392897707777464645422828282828284-170000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-09-30)

Gross Profit (+$)
totalRevenue1,952
Cost of Revenue-1,496
Gross Profit457457
 
Operating Income (+$)
Gross Profit457
Operating Expense-12,412
Operating Income-11,955-11,955
 
Operating Expense (+$)
Research Development6,941
Selling General Administrative6,753
Selling And Marketing Expenses173
Operating Expense12,41213,867
 
Net Interest Income (+$)
Interest Income0
Interest Expense-0
Other Finance Cost-0
Net Interest Income0
 
Pretax Income (+$)
Operating Income-11,955
Net Interest Income0
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-11,859-12,051
EBIT - interestExpense = -11,955
-12,059
-11,859
Interest Expense0
Earnings Before Interest and Taxes (EBIT)-11,955-11,859
Earnings Before Interest and Taxes (EBITDA)-11,756
 
After tax Income (+$)
Income Before Tax-11,859
Tax Provision-0
Net Income From Continuing Ops-11,859-11,859
Net Income-11,859
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses13,908
Total Other Income/Expenses Net960
 

Technical Analysis of Neuroone Medical Technologies Corp
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Neuroone Medical Technologies Corp. The general trend of Neuroone Medical Technologies Corp is BEARISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Neuroone Medical Technologies Corp's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-28.6%) Bearish trend (28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Neuroone Medical Technologies Corp.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 1.47 < 1.59 < 1.72.

The bearish price targets are: 1.01 > 0.9522 > 0.86.

Tweet this
Neuroone Medical Technologies Corp Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Neuroone Medical Technologies Corp. The current mas is .

The long score for the Moving Averages is 5/14.
The longshort score for the Moving Averages is -4/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Neuroone Medical Technologies Corp Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Neuroone Medical Technologies Corp. The current macd is -0.00856306.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Neuroone Medical Technologies Corp price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Neuroone Medical Technologies Corp. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Neuroone Medical Technologies Corp price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Neuroone Medical Technologies Corp Daily Moving Average Convergence/Divergence (MACD) ChartNeuroone Medical Technologies Corp Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Neuroone Medical Technologies Corp. The current adx is 16.00.

The long score for the Directional Movement Index (DMI) is 2/7.
The longshort score for the Directional Movement Index (DMI) is 2/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Neuroone Medical Technologies Corp shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bullish trend could be forming. +1
Neuroone Medical Technologies Corp Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Neuroone Medical Technologies Corp. The current sar is 1.1.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Neuroone Medical Technologies Corp Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Neuroone Medical Technologies Corp. The current rsi is 51.30. The current phase is Correction in bear market.

The long score for the Relative Strength Index (RSI) is 3/13.
The longshort score for the Relative Strength Index (RSI) is 2/(-13 +13).

  • Correction in bear market: Extended price decline in a downtrend, significant pullback. Consider reducing exposure, wait for signs of trend reversal.
  • Trending down: The RSI is trending down. -1
Neuroone Medical Technologies Corp Daily Relative Strength Index (RSI) ChartNeuroone Medical Technologies Corp Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Neuroone Medical Technologies Corp. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Neuroone Medical Technologies Corp price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Neuroone Medical Technologies Corp Daily Stochastic Oscillator ChartNeuroone Medical Technologies Corp Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Neuroone Medical Technologies Corp. The current cci is 22.61.

Neuroone Medical Technologies Corp Daily Commodity Channel Index (CCI) ChartNeuroone Medical Technologies Corp Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Neuroone Medical Technologies Corp. The current cmo is 6.9413079.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Neuroone Medical Technologies Corp Daily Chande Momentum Oscillator (CMO) ChartNeuroone Medical Technologies Corp Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Neuroone Medical Technologies Corp. The current willr is -61.2244898.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Neuroone Medical Technologies Corp is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Neuroone Medical Technologies Corp Daily Williams %R ChartNeuroone Medical Technologies Corp Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Neuroone Medical Technologies Corp.

Neuroone Medical Technologies Corp Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Neuroone Medical Technologies Corp. The current atr is 0.13601829.

Neuroone Medical Technologies Corp Daily Average True Range (ATR) ChartNeuroone Medical Technologies Corp Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Neuroone Medical Technologies Corp. The current obv is 25,418,444.

Neuroone Medical Technologies Corp Daily On-Balance Volume (OBV) ChartNeuroone Medical Technologies Corp Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Neuroone Medical Technologies Corp. The current mfi is 35.28.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Neuroone Medical Technologies Corp Daily Money Flow Index (MFI) ChartNeuroone Medical Technologies Corp Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Neuroone Medical Technologies Corp.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-11-09ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-15MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-16RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-17MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-20STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-21STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2023-11-28STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2023-11-30SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-04STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-12-05STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-11RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-12SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-27DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-01-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-08DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-09SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-16CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-17STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-24WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-25CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-29STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-30STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-02MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-05STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-09MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-22STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-23WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-04SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-06CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-03-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-21STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-03-26STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-27CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-28STOCH SHORT EXITThe %K line crosses above the %D line.

6.3. Candlestick Patterns

Neuroone Medical Technologies Corp Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Neuroone Medical Technologies Corp based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5051.303
Ma 20Greater thanMa 501.175
Ma 50Greater thanMa 1001.215
Ma 100Greater thanMa 2001.320
OpenGreater thanClose1.190
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Neuroone Medical Technologies Corp with someone you think should read this too:
  • Are you bullish or bearish on Neuroone Medical Technologies Corp? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Neuroone Medical Technologies Corp? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Neuroone Medical Technologies Corp

I send you an email if I find something interesting about Neuroone Medical Technologies Corp.


Comments

How you think about this?

Leave a comment

Stay informed about Neuroone Medical Technologies Corp.

Receive notifications about Neuroone Medical Technologies Corp in your mailbox!